参考文献:1.Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009;374(9685):239鈥?9.CrossRef PubMed 2.Cheng L, Davison DD, Adams J, Lopez-Beltran A, Wang L, Montironi R, et al. Biomarkers in bladder cancer: translational and clinical implications. Crit Rev Oncol Hematol. 2014;89(1):73鈥?11.CrossRef PubMed 3.Chen LL, Carmichael GG. Decoding the function of nuclear long noncoding RNAs. Curr Opin Cell Biol. 2010;22(3):357鈥?4.PubMed Central CrossRef PubMed 4.Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339(2):159鈥?6.CrossRef PubMed 5.Prensner JR, Iyer MK, Balbin OA, Dhanasekaran SM, Cao Q, Brenner JC, et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol. 2011;29(8):742鈥?.PubMed Central CrossRef PubMed 6.Ge X, Chen Y, Liao X, Liu D, Li F, Ruan H, et al. Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer. Med Oncol. 2013;30(2):588.CrossRef PubMed 7.Prensner JR, Chen W, Iyer MK, Cao Q, Ma T, Han S, et al. PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer. Cancer Res. 2014;74(6):1651鈥?0.PubMed Central CrossRef PubMed 8.Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L, et al. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet. 2013;45(11):1392鈥?.CrossRef PubMed 9.Feldstein O, Nizri T, Doniger T, Jacob J, Rechavi G, Ginsberg D. The long non-coding RNA ERIC is regulated by E2F and modulates the cellular response to DNA damage. Mol Cancer. 2013;12(1):131.PubMed Central CrossRef PubMed 10.Prensner JR, Chen W, Han S, Iyer MK, Cao Q, Kothari V, et al. The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc. Neoplasia. 2014;16(11):900鈥?.PubMed Central CrossRef PubMed
作者单位:Li Liu (1) (2) Yuchen Liu (1) Chengle Zhuang (1) (2) Wen Xu (3) Xing Fu (1) Zhaojie Lv (1) Hanwei Wu (1) Lisha Mou (1) Guoping Zhao (1) (4) Zhiming Cai (1) (2) Weiren Huang (1)
1. Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People鈥檚 Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China 2. Shantou University Medical College, Shantou, China 3. State Key Laboratory Biocontrol, Institute of Aquatic Economic Animals and Guangdong Provincial Key Laboratory for Aquatic Economic Animals, School of Life Sciences, Sun Yat-sen University, Guangzhou, China 4. Shanghai-MOST Key Laboratory of Health and Disease Genomics, Chinese National Human Genome Center at Shanghai, Shanghai, China
刊物主题:Cancer Research;
出版者:Springer Netherlands
ISSN:1423-0380
文摘
Long non-coding RNAs (lncRNAs) are a class of non-coding RNAs that play important roles in cancer development and progression. Prostate cancer-associated transcript 1 (PCAT-1) is a novel lncRNA that promotes cell proliferation in prostate cancer. We hypothesized that PCAT-1 also have roles in bladder cancer. In this study, we found that PCAT-1 was up-regulated in bladder cancer compared to paired normal urothelium. Cell proliferation inhibition and apoptosis induction were also observed in PCAT-1 small hairpin RNA (shRNA)-transfected bladder cancer T24 and 5637 cells. Our data suggest that PCAT-1 plays oncogenic roles and can be used as a therapeutic target for treating human bladder cancer. Keywords PCAT-1 Bladder cancer Proliferation Apoptosis